Enfamil

Search documents
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 4, 2025 in Reckitt Benckiser Group plc Lawsuit – RBGLY
GlobeNewswire News Room· 2025-08-04 20:23
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY). Shareholders who purchased shares of RBGLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/reckitt-benckiser-group-plc-loss-submission-form-2/?id=159236&from=3 ...
RBGLY DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important August 4 Deadline in Securities Class Action – RBGLY
GlobeNewswire News Room· 2025-08-03 15:03
Core Viewpoint - The Rosen Law Firm is reminding purchasers of Reckitt Benckiser Group PLC's American Depositary Shares (ADSs) of a class action lawsuit with a lead plaintiff deadline of August 4, 2025, for those who bought shares between January 13, 2021, and July 28, 2024 [1][2]. Group 1: Class Action Details - Investors who purchased Reckitt ADSs during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the deadline [2]. - The lawsuit alleges that Reckitt failed to warn investors about the increased risk of necrotizing enterocolitis (NEC) in preterm infants due to its cow's milk-based formula, Enfamil, which misled investors regarding the company's business prospects [4]. Group 2: Rosen Law Firm's Credentials - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [3]. - The firm has been consistently ranked among the top firms for securities class action settlements, recovering hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3].
RECKITT (RBGLY) URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Reckitt Benckiser Group plc and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-08-02 14:21
Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group plc for allegedly misleading investors regarding the risks associated with its cow's milk-based formula, Enfamil, which is linked to a serious health risk in premature infants [1][4]. Group 1: Lawsuit Details - The class action lawsuit is filed in the United States District Court for the Southern District of New York on behalf of investors who purchased Reckitt securities between January 13, 2021, and July 28, 2024 [1]. - Investors have until August 4, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. - The lawsuit claims that Reckitt failed to adequately warn about the increased risk of necrotizing enterocolitis (NEC) in premature infants consuming its formula [3][4]. Group 2: Allegations Against Reckitt - The lawsuit alleges that Reckitt made misleading statements and omissions regarding its business, financial condition, and prospects during the class period [4]. - Specific allegations include failing to disclose the risks associated with Enfamil, the potential impact on sales, and the exposure to legal claims [4]. - As a result of these omissions, Reckitt's positive statements about its business were deemed materially false and misleading [4]. Group 3: Company Background - Reckitt is a UK-based global consumer goods company facing over 500 product liability lawsuits related to its infant formula [3]. - The lawsuits claim that Reckitt and its competitor Abbott Laboratories did not adequately warn about the risks associated with their cow milk-based formulas [3]. Group 4: Legal Representation - Bragar Eagel & Squire, P.C. is representing the investors in this class action lawsuit and encourages affected individuals to reach out for more information [1][5]. - The firm specializes in representing individual and institutional investors in complex litigation [6].
Shareholders of Reckitt Benckiser Group plc Should Contact The Gross Law Firm Before August 4, 2025 to Discuss Your Rights - RBGLY
Prnewswire· 2025-07-31 12:45
NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Reckitt Benckiser Group plc (OTCQX: RBGLY).Shareholders who purchased shares of RBGLY during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/reckitt-benckiser-group-plc-loss-submission-form-2/?id=158784&from=4CLASS PE ...
RECKITT (RBGLY) DEADLINE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Reckitt Benckiser Group plc and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-07-28 23:09
Core Viewpoint - A class action lawsuit has been filed against Reckitt Benckiser Group plc for allegedly misleading investors regarding the risks associated with its cow's milk-based formula, Enfamil, during the class period from January 13, 2021, to July 28, 2024 [1][4]. Company Overview - Reckitt Benckiser Group plc is a UK-based global consumer goods company facing over 500 state and federal product liability lawsuits related to its cow's milk-based formula, Enfamil, and its competitor Abbott Laboratories' Similac [3]. Legal Allegations - The class action lawsuit claims that Reckitt made misleading statements and omissions about its business and financial condition, specifically failing to disclose the increased risk of necrotizing enterocolitis (NEC) for preterm infants consuming its formula [4]. - The lawsuit alleges that Reckitt did not adequately warn investors about the potential impact on sales and legal exposure related to the NEC risk associated with its products [4].
Reckitt Benckiser Group PLC Investors: Please contact the Portnoy Law Firm to recover your losses; August 4, 2025 Deadline to file Lead Plaintiff Motion
GlobeNewswire News Room· 2025-07-28 20:44
Core Viewpoint - Reckitt Benckiser Group PLC is facing a class action lawsuit from investors due to alleged misleading statements and failure to disclose health risks associated with its Enfamil infant formula, leading to significant stock price declines [3][4][5]. Group 1: Class Action Details - The class action represents investors who purchased Reckitt Benckiser securities between January 13, 2021, and July 28, 2024, with a deadline for filing a lead plaintiff motion set for August 4, 2025 [1]. - The lawsuit claims that Reckitt Benckiser did not adequately warn consumers and investors about the increased risk of Necrotizing Enterocolitis (NEC) for preterm infants consuming its cow's milk-based formula [3]. Group 2: Legal Outcomes and Financial Impact - A jury verdict on March 15, 2024, found Mead Johnson negligent, resulting in a $60 million award for failing to warn about NEC risks, which caused Reckitt Benckiser's American Depositary Shares (ADSs) to drop nearly 14% [4]. - Following a related case on July 29, 2024, where a Missouri jury awarded $495 million in damages over NEC caused by a competing formula, Reckitt Benckiser's ADSs fell nearly 9% [5].
August 4, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against RBGLY
Prnewswire· 2025-07-28 12:45
Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit alleging misleading statements related to the company's cow's milk-based formula, Enfamil, which may have increased health risks for preterm infants [1][2]. Group 1: Allegations and Class Period - The class period for the allegations is from January 13, 2021, to July 28, 2024 [1]. - The complaint claims that Reckitt failed to disclose that preterm infants were at an increased risk of developing NEC from consuming Enfamil [1]. - It is alleged that Reckitt's positive statements about its business and operations were materially false and misleading due to the undisclosed risks and potential legal claims [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by the deadline of August 4, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [3].
Reckitt Benckiser Group plc Class Action: Levi & Korsinsky Reminds Reckitt Benckiser Group plc Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 4, 2025 – RBGLY
GlobeNewswire News Room· 2025-07-25 20:34
NEW YORK, July 25, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team: h ...
Shareholders that lost money on Reckitt Benckiser Group plc (RBGLY) should contact Levi & Korsinsky about pending Class Action - RBGLY
Prnewswire· 2025-07-25 12:45
NEW YORK, July 25, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc" or the "Company") (OTCQX: RBGLY) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Reckitt Benckiser Group plc investors who were adversely affected by alleged securities fraud between January 13, 2021 and July 28, 2024. Follow the link below to get more information and be contacted by a member of our team:https:/ ...
Class Action Filed Against Reckitt Benckiser Group plc (RBGLY) - August 4, 2025 Deadline to Join – Contact The Gross Law Firm
GlobeNewswire News Room· 2025-07-24 20:00
Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit related to misleading statements and omissions concerning the company's cow's milk-based formula, Enfamil, which allegedly increased the risk of NEC in preterm infants [1][3]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 13, 2021, to July 28, 2024 [3]. - Allegations include that Reckitt failed to disclose the increased risk of NEC for preterm infants consuming Enfamil, the impact on sales, and the exposure to legal claims, leading to materially false and misleading statements about the company's business and prospects [3]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of August 4, 2025, to potentially become lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements or omissions [5].